Kazuya Kondo Selected Research

glutamate decarboxylase 1

6/2021	GAD1 expression and its methylation as indicators of malignant behavior in thymic epithelial tumors.
1/2019	Prognostic significance of GAD1 overexpression in patients with resected lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuya Kondo Research Topics

Disease

45	Neoplasms (Cancer) 01/2022 - 03/2002
35	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2002
16	Thymoma (Thymic Carcinoma) 11/2021 - 09/2003
13	Carcinogenesis 01/2022 - 03/2002
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 11/2003
7	Neoplasm Metastasis (Metastasis) 03/2019 - 03/2004
5	Lymphatic Metastasis 04/2020 - 03/2004
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2021 - 05/2006
3	Myasthenia Gravis 01/2021 - 07/2005
3	Microsatellite Instability 01/2020 - 03/2002
3	Hypoxia (Hypoxemia) 10/2019 - 08/2013
3	Body Weight (Weight, Body) 03/2019 - 09/2005
3	Adenocarcinoma of Lung 01/2019 - 02/2016
3	Carcinoma (Carcinomatosis) 02/2011 - 12/2003
3	Adenocarcinoma 07/2010 - 03/2006
2	Hepatocellular Carcinoma (Hepatoma) 03/2019 - 12/2016
1	Hemorrhage 08/2021
1	Lymphoma (Lymphomas) 12/2020
1	Anaplastic Thyroid Carcinoma 10/2020
1	Pneumonia (Pneumonitis) 01/2018
1	Margins of Excision 12/2016
1	Breast Neoplasms (Breast Cancer) 03/2016
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 07/2015

Drug/Important Bio-Agent (IBA)

9	ChromatesIBA 01/2022 - 03/2002
9	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2003
8	chromium hexavalent ionIBA 01/2022 - 05/2006
5	Messenger RNA (mRNA)IBA 11/2021 - 11/2004
5	ChromiumIBA 02/2011 - 03/2002
4	CarcinogensIBA 01/2022 - 12/2003
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021 - 12/2016
4	ErbB Receptors (EGF Receptor)IBA 10/2019 - 01/2015
4	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2018 - 03/2005
3	SuspensionsIBA 01/2022 - 11/2003
3	LigandsIBA 11/2021 - 01/2015
3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 08/2009
3	UracilIBA 01/2018 - 03/2005
3	TegafurIBA 01/2018 - 03/2005
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2011 - 08/2005
2	Ghrelin ReceptorsIBA 11/2021 - 01/2020
2	glutamate decarboxylase 1IBA 06/2021 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2006
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 08/2009
2	Glucose (Dextrose)FDA LinkGeneric 02/2016 - 08/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 08/2013
2	LipidsIBA 07/2015 - 01/2014
2	Antineoplastic Agents (Antineoplastics)IBA 02/2015 - 08/2009
2	AcidsIBA 10/2011 - 07/2009
2	Thymidylate SynthaseIBA 07/2007 - 03/2005
2	Matrix Metalloproteinases (MMPs)IBA 09/2005 - 11/2003
2	Indicators and Reagents (Reagents)IBA 01/2005 - 04/2004
2	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2003 - 01/2003
1	N-methyladenosineIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	6-methyladenineIBA 01/2022
1	MethyltransferasesIBA 01/2022
1	AgarIBA 01/2022
1	B-Cell Activation Factor ReceptorIBA 11/2021
1	GhrelinIBA 11/2021
1	CXC ChemokinesIBA 11/2021
1	S100 Proteins (S 100 Protein)IBA 12/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2020
1	lenvatinibIBA 10/2020
1	Hematoxylin (Haematoxylon)IBA 04/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2020
1	hydrogen sulfite (bisulfite)IBA 01/2020
1	Cholinergic ReceptorsIBA 01/2020
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	BilirubinIBA 01/2018
1	OsteopontinIBA 01/2018
1	CC ChemokinesIBA 01/2018
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2018
1	Captopril (Capoten)FDA LinkGeneric 02/2016
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	p38 Mitogen-Activated Protein KinasesIBA 01/2016
1	MetalsIBA 01/2016
1	Angiogenic ProteinsIBA 01/2016
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2016
1	ProdrugsIBA 07/2015
1	NanocapsulesIBA 07/2015
1	Gemcitabine FDA Link 07/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 10/2020 - 09/2003
9	Therapeutics 10/2020 - 01/2002
6	Lymph Node Excision (Lymph Node Dissection) 11/2021 - 08/2010
6	Thymectomy 01/2021 - 07/2005
6	Radiotherapy 12/2017 - 09/2003
3	Photochemotherapy (Photodynamic Therapy) 02/2011 - 08/2005
2	Aftercare (After-Treatment) 01/2019 - 02/2016
2	Adjuvant Chemotherapy 01/2018 - 03/2005
2	Transplantation 07/2015 - 03/2004
1	Segmental Mastectomy (Lumpectomy) 11/2021
1	Lasers (Laser) 08/2021
1	Operative Time 08/2021
1	Intravenous Administration 03/2019
1	Thoracoscopes 03/2018
1	Metastasectomy 12/2016
1	Plasmapheresis 03/2016
1	Operative Surgical Procedures 03/2016
1	Subcutaneous Injections 07/2015